Metraipolis › archive › dc_e94da16fd4ad

Targeting CAMK1D-engineered nanoactivator suppresses cancer stem cell maintenance and immune evasion in enzalutamide-resistant prostate cancer — Europe PMC PMID:41510165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41510165
DOI
10.7150/thno.120826
License (as archived)
solo-consultazione
Archived
2026-11-07T04:32:29.230Z
SHA-256 of the archived text
899599e48a314394b94e92255148e885cefba297d67ff0894637508d63d2851e
Stable URL of this page
https://metraipolis.com/documento/dc_e94da16fd4ad

How to cite

Targeting CAMK1D-engineered nanoactivator suppresses cancer stem cell maintenance and immune evasion in enzalutamide-resistant prostate cancer — Europe PMC PMID:41510165 — Europe PMC (en), https://europepmc.org/article/MED/41510165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e94da16fd4ad (Metraipolis archive dc_e94da16fd4ad, sha256 899599e48a314394b94e92255148e885cefba297d67ff0894637508d63d2851e)
BibTeX
@misc{dce94da16fd4ad,
  title = {Targeting CAMK1D-engineered nanoactivator suppresses cancer stem cell maintenance and immune evasion in enzalutamide-resistant prostate cancer — Europe PMC PMID:41510165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41510165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e94da16fd4ad; sha256 899599e48a314394b94e92255148e885cefba297d67ff0894637508d63d2851e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41510165. Agents can read the archived copy with the MCP tool read_document.